Approval · Notice of Compliance 37006 · 2026
EUGIA-HYDROXYUREA: Notice of Compliance 37006
Issued February 27, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37006
- Date
- February 27, 2026
- Company
- Eugia Pharma Inc.Woodbridge, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to Product Monograph
- Canadian reference product
- HYDREA (Bristol-Myers Squibb Canada)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EUGIA-HYDROXYUREA | Not yet assigned | — |
Medicinal ingredients
- HYDROXYUREA 500 MG per CAP